News.

Stay up to date.

Press Releases.

News.

NEWS - Mainz, 30.4.2025

Dr. Beatrix Förster, founder and CEO of Doderm GmbH, inspires startup teams at the LiSci Incubator!


On Tuesday, May 20th, Dr. Förster will give an inspiring talk as part of the third workshop of the first incubation round on the topic of founding and entrepreneurship in the life science sector.


Biography

Dr. Beatrix Förster is the founder, CEO, and scientific director of Doderm. She is an expert in immunotherapies with over 20 years of experience. She has held research and leadership positions, including at the Max Planck Institute for Biochemistry, the biopharmaceutical company TRION Research GmbH, Stanford University, and Utrecht University. Additionally, she has professional experience in project management, consulting, and business development at the interface of academia and industry.


The Company – Doderm GmbH

Antibiotic resistance (AMR) is one of the greatest global threats to public health and development. Doderm offers an innovative way for people to manage their own skin conditions and those of their pets while reducing dependence on antibiotics and cortisone. Doderm has developed products that balance the microbiome, stabilizing the skin to keep it healthy. Doderm's vision is to revolutionize the way infections and inflammations are treated, shifting from problem-solving to prevention in order to sustainably reduce antibiotic consumption and antibiotic resistance.

https://www.doderm.eu

NEWS - Mainz, April 11th, 2025  

Four New Startup Teams Entering the Incubation Program!


With our Mentor Meetup on April 11, 2025, at the Life Science Center Mainz, the [LiSci]RLP incubator program entered its next round — with fantastic support from the Ministry of Economic Affairs, Transport, Agriculture and Viticulture of Rhineland-Palatinate.


After the success of the first round, we’re now moving forward with not just three, but four innovative teams from the fields of life sciences and biotechnology.


At our Mentor Meetup, the four startup teams engaged in an intensive exchange with experts from the pharmaceutical and biotechnology sectors to select their mentors for the upcoming incubation year.


An overview of the teams:

  • ORVAX Therapeutics – RNA-based vaccines against infectious diseases
  • CYCLOX – Platform for the sustainable production of natural active ingredients
  • SMAC – Contract analytics for polymers in biotechnology
  • Alsterrlab – Multifunctional medical yarns infused with high-tech active agents

The growing number of participants at our Mentor Meetup highlights the strong interest from life sciences experts in actively shaping and supporting the future of this promising sector in Rhineland-Palatinate.


We’re incredibly excited about the months ahead with these dedicated startup teams — and about many upcoming innovations “made in Rhineland-Palatinate”!

More news to come soon!